Samil Pharm Cash Flow Reinvestment Rate
Samil Pharm cash flow reinvestment rate. Samil Pharm (000520) has a Cash Flow Reinvestment Rate of 2.71x as of June 2025, reinvesting ₩6.62 Billion (capex ₩3.26 Billion plus investments ₩-3.36 Billion) from operating cash flow of ₩2.44 Billion. See Samil Pharm leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Samil Pharm (2012–2024)
Cash flow reinvestment rate of Samil Pharm from 2012 to 2024. Historical reinvestment intensity for Samil Pharm across 10 annual periods. Explore Samil Pharm cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Samil Pharm Cash Flow Reinvestment Rate by Year (2012–2024)
Samil Pharm cash flow reinvestment rate by year from 2012 to 2024. Year-by-year capital reinvestment analysis for Samil Pharm. For the full cash flow conversion analysis, see 000520 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.62x | ₩11.97 Billion | ₩2.59 Billion | ₩5.61 Billion | ▲ +22.9% |
| 2023 | 3.76x | ₩44.17 Billion | ₩11.75 Billion | ₩24.39 Billion | ▼ -73.9% |
| 2022 | 14.38x | ₩59.74 Billion | ₩4.15 Billion | ₩48.48 Billion | ▼ -52.2% |
| 2021 | 30.09x | ₩42.63 Billion | ₩1.42 Billion | ₩32.83 Billion | ▲ +711.2% |
| 2020 | 3.71x | ₩28.83 Billion | ₩7.77 Billion | ₩17.02 Billion | ▲ +117.0% |
| 2019 | 1.71x | ₩18.10 Billion | ₩10.59 Billion | ₩13.89 Billion | ▼ -84.7% |
| 2017 | 11.19x | ₩42.41 Billion | ₩3.79 Billion | ₩36.33 Billion | ▲ +762.2% |
| 2016 | 1.30x | ₩7.31 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -69.9% |
| 2015 | 4.31x | ₩12.60 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +1035.7% |
| 2012 | 0.38x | ₩1.91 Billion | ₩5.02 Billion | ₩1.91 Billion | — |